These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34760642)

  • 1. Role of investigational new drug committees in propelling the drug development ecosystem in India.
    Davis S
    Perspect Clin Res; 2021; 12(4):177-178. PubMed ID: 34760642
    [No Abstract]   [Full Text] [Related]  

  • 2. How to ascertain drug related deaths during clinical trials ?
    Lele RD
    J Assoc Physicians India; 2013 Oct; 61(10):733-7. PubMed ID: 24772730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Bayesian dose-finding trial with adaptive dose expansion to flexibly assess efficacy and safety of an investigational drug.
    Berry SM; Spinelli W; Littman GS; Liang JZ; Fardipour P; Berry DA; Lewis RJ; Krams M
    Clin Trials; 2010 Apr; 7(2):121-35. PubMed ID: 20338905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigational drugs and research.
    Tueting P
    Psychiatr Med; 1991; 9(2):333-47. PubMed ID: 1857767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-trial access to investigational drugs in India: addressing challenges in the regulatory framework.
    Mehrotra N; Manchikanti P
    Med Law Rev; 2024 Feb; 32(1):20-41. PubMed ID: 37616571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Reorganization of the procedures and the tasks of the responsible ethics committees after the 12th AMG amendment. Concepts of the permanent working group of the medical ethics committees in Germany].
    Wessler I; Burger R; Doppelfeld E
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Feb; 48(2):155-67. PubMed ID: 15726456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug companies cut costs with foreign clinical trials.
    Rai S
    N Y Times Web; 2005 Feb; ():C4. PubMed ID: 15742516
    [No Abstract]   [Full Text] [Related]  

  • 8. Are village health sanitation and nutrition committees fulfilling their roles for decentralised health planning and action? A mixed methods study from rural eastern India.
    Srivastava A; Gope R; Nair N; Rath S; Rath S; Sinha R; Sahoo P; Biswal PM; Singh V; Nath V; Sachdev HP; Skordis-Worrall J; Haghparast-Bidgoli H; Costello A; Prost A; Bhattacharyya S
    BMC Public Health; 2016 Jan; 16():59. PubMed ID: 26795942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic uses of investigational drugs: research extension, compassionate use, and expanded access].
    Goldim JR
    Rev Panam Salud Publica; 2008 Mar; 23(3):198-206. PubMed ID: 18397586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommendations from the Investigational New Drug/Investigational Device Exemption Task Force of the clInical and Translational Science Award Consortium: developing and implementing a sponsor-investigators training program.
    Holbein ME; Berglund JP; O'Reilly EK; Hartman K; Speicher LA; Adamo JE; O'Riordan G; Brown JS; Schuff KG;
    J Investig Med; 2014 Jun; 62(5):797-803. PubMed ID: 24831858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A two-year evaluation of the minutes of Investigational New Drug committee meetings.
    Raj JP; Gogtay NJ; Thatte UM
    Perspect Clin Res; 2021; 12(4):199-202. PubMed ID: 34760647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Informed consent and investigational new drug abuses in the U.S. military.
    Cummings ML
    Account Res; 2002; 9(2):93-103. PubMed ID: 12625353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ASHP Guidelines for the Management of Investigational Drug Products.
    Kay SC; Luke DG; Tamer HR
    Am J Health Syst Pharm; 2018 Apr; 75(8):561-573. PubMed ID: 29626006
    [No Abstract]   [Full Text] [Related]  

  • 14. Ethics committees in India: Facing the challenges!
    Kadam R; Karandikar S
    Perspect Clin Res; 2012 Apr; 3(2):50-6. PubMed ID: 22701820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The challenges of institutionalizing community-level social accountability mechanisms for health and nutrition: a qualitative study in Odisha, India.
    Feruglio F; Nisbett N
    BMC Health Serv Res; 2018 Oct; 18(1):788. PubMed ID: 30340490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing Institutional Ethics Committees in India Using the IRB-RAT.
    Chenneville T; Menezes L; Bylsma LM; Mann A; Kosambiya J; Baxi R
    J Empir Res Hum Res Ethics; 2014 Oct; 9(4):50-9. PubMed ID: 25747296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profiles of institutional ethics committees and status of standard operating procedures in North East India.
    Das BR; Kakoti G
    Indian J Med Ethics; 2021; VI(2):1-17. PubMed ID: 33908366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethics committees and clinical trials registration in India: opportunities, obligations, challenges and solutions.
    Tharyan P
    Indian J Med Ethics; 2007; 4(4):168-9. PubMed ID: 18630235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The investigational new drug application--who benefits?
    Freireich EJ
    Nat Clin Pract Oncol; 2006 Feb; 3(2):62-3. PubMed ID: 16462826
    [No Abstract]   [Full Text] [Related]  

  • 20. Why wasn't an investigational new drug (IND) application required before appropriate study?
    Maloney DM
    Hum Res Rep; 2004 Mar; 19(3):6-7. PubMed ID: 15139342
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.